Delivery Order SPE2DR25D1104-SPE2DR26FL108
- Not listed
- The Defense Logistics Agency awarded a $25,216.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp (subsidiary of parent company Cencora, Inc.) on January 8, 2026, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, with an ultimate completion date of January 9, 2026, will be fulfilled at the awardee's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, demonstrating AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a $31,730.30 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Zepbound 10 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by December 30, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency has awarded a delivery order valued at $9,204.95 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injectors. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of November 3, 2025. The award represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with a ceiling value of $1,845.70 and an ultimate completion date of December 2, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,607.32 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors (0.5 mL) on January 7, 2026, with completion required by January 8, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $22,169.75 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on January 28, 2026, with completion scheduled for January 29, 2026. This is a firm fixed-price order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $13,854.10 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pen injectors, with an ultimate completion date of January 15, 2026. This is a firm fixed-price delivery order with no set-aside designation, executed as a competitive award. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing...
- The Defense Logistics Agency has awarded a delivery order valued at $3,616.38 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors. The order, issued on December 30, 2025, with completion targeted for December 31, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is fulfilling this order through its Corporate Office division. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,143.87 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The order represents a child delivery order under a larger contract vehicle, enabling the pharmaceutical distributor to supply critical medical...
- The Defense Logistics Agency awarded a delivery order valued at $16,154.85 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under the company's larger Indefinite...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FL108Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,850.55 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injectors. The contract was executed on February 2, 2026, with an ultimate completion date of February 3, 2026, and utilized firm fixed-price pricing with no set-aside designation. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's IDC with DLA provides a comprehensive global pharmaceutical support vehicle enabling supply of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The current delivery order for Zepbound, a diabetes medication, exemplifies the breadth of pharmaceutical products AmerisourceBergen supplies through its prime contract with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 2/1/26 |